Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease

Cell

Volumn 170, Issue 2, 2017, Pages 273-283.e12

  Richner, Justin M ^a,h   Jagger, Brett W ^a   Shan, Chao ^b   Fontes, Camila R ^b   Dowd, Kimberly A ^c   Cao, Bin ^a   Himansu, Sunny ^d   Caine, Elizabeth A ^a   Nunes, Bruno T D ^b,e   Medeiros, Daniele B A ^b,e   Muruato, Antonio E ^b   Foreman, Bryant M ^c   Luo, Huanle ^b   Wang, Tian ^b   Barrett, Alan D ^b   Weaver, Scott C ^b,f   Vasconcelos, Pedro F C ^e,g   Rossi, Shannan L ^b,f   Ciaramella, Giuseppe ^d   Mysorekar, Indira U ^a   Pierson, Theodore C ^c   Shi, Pei Yong ^b,f   Diamond, Michael S ^a   more..

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d MODERNA THERAPEUTICS   (United States)

^e INSTITUTO EVANDRO CHAGAS   (Brazil)

^f UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^g UNIVERSIDADE DO ESTADO DO PARÁ   (Brazil)

^h IIT RESEARCH INSTITUTE   (United States)

Author keywords

antibody; fetus; flavivirus; immunity; microcephaly; pregnancy; transmission; Vaccine

Indexed keywords

LIPID NANOPARTICLE; LIVE ATTENUATED ZIKA VIRUS VACCINE; LIVE VACCINE; NANOPARTICLE; NONSTRUCTURAL PROTEIN 1; PLACEBO; PRM E MESSENGER RNA ZIKA VIRUS VACCINE; UNCLASSIFIED DRUG; VIRUS RNA; ZIKA VIRUS VACCINE; LIPID; MESSENGER RNA; NEUTRALIZING ANTIBODY; NS1 PROTEIN, ZIKA VIRUS; SUBUNIT VACCINE; VIRAL PROTEIN; VIRUS ANTIBODY; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONGENITAL MALFORMATION; CONTROLLED STUDY; DRUG EFFICACY; EMBRYO; FEMALE; FETUS; FETUS DEATH; FETUS TISSUE; IMMUNIZATION; MALE; MOUSE; NANOENCAPSULATION; NONHUMAN; PLACENTA DISORDER; PLACENTA TISSUE; PRIORITY JOURNAL; PROTECTION; SINGLE DRUG DOSE; VACCINE IMMUNOGENICITY; VERTICAL TRANSMISSION; VIRUS E GENE; VIRUS GENE; VIRUS INHIBITION; VIRUS LOAD; VIRUS PRM GENE; VIRUS STRAIN; ZIKA FEVER; AEDES; ANIMAL; BLOOD; BLOOD CELL; C57BL MOUSE; GENETICS; GERMFREE ANIMAL; HUMAN; IMMUNOLOGY; MAMMALIAN EMBRYO; MUTATION; PHYSIOLOGY; VIROLOGY; ZIKA VIRUS; ZIKA VIRUS INFECTION;

AEDES; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; BLOOD CELLS; EMBRYO, MAMMALIAN; FEMALE; FETUS; HUMANS; LIPIDS; MALE; MICE; MICE, INBRED C57BL; MUTATION; RNA, MESSENGER; SPECIFIC PATHOGEN-FREE ORGANISMS; VACCINES, SUBUNIT; VIRAL NONSTRUCTURAL PROTEINS; VIRAL VACCINES; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 85023598743     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2017.06.040     Document Type: Article

References (53)

1. Abbink, P., Larocca, R.A., De La Barrera, R.A., Bricault, C.A., Moseley, E.T., Boyd, M., Kirilova, M., Li, Z., Ng'ang'a, D., Nanayakkara, O., et al. Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys. Science 353 (2016), 1129–1132.
2. Brasil, P., Pereira, J.P. Jr., Moreira, M.E., Ribeiro Nogueira, R.M., Damasceno, L., Wakimoto, M., Rabello, R.S., Valderramos, S.G., Halai, U.A., Salles, T.S., et al. Zika Virus Infection in Pregnant Women in Rio de Janeiro. N. Engl. J. Med. 375 (2016), 2321–2334.
3. Brien, J.D., Lazear, H.M., Diamond, M.S., Propagation, quantification, detection, and storage of West Nile virus. Curr. Protoc. Microbiol., 31, 2013, 1 18.
4. Cao-Lormeau, V.M., Blake, A., Mons, S., Lastère, S., Roche, C., Vanhomwegen, J., Dub, T., Baudouin, L., Teissier, A., Larre, P., et al. Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet 387 (2016), 1531–1539.
5. Dick, G.W., Zika virus. II. Pathogenicity and physical properties. Trans. R. Soc. Trop. Med. Hyg. 46 (1952), 521–534.
6. Dowd, K.A., DeMaso, C.R., Pierson, T.C., Genotypic Differences in Dengue Virus Neutralization Are Explained by a Single Amino Acid Mutation That Modulates Virus Breathing. MBio, 6, 2015 e01559–e15.
7. Dowd, K.A., DeMaso, C.R., Pelc, R.S., Speer, S.D., Smith, A.R., Goo, L., Platt, D.J., Mascola, J.R., Graham, B.S., Mulligan, M.J., et al. Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype. Cell Rep. 16 (2016), 1485–1491.
8. Dowd, K.A., Ko, S.Y., Morabito, K.M., Yang, E.S., Pelc, R.S., DeMaso, C.R., Castilho, L.R., Abbink, P., Boyd, M., Nityanandam, R., et al. Rapid development of a DNA vaccine for Zika virus. Science 354 (2016), 237–240.
9. Durbin, A.P., Vaccine Development for Zika Virus-Timelines and Strategies. Semin. Reprod. Med. 34 (2016), 299–304.
10. Faria, N.R., Azevedo, Rdo.S., Kraemer, M.U., Souza, R., Cunha, M.S., Hill, S.C., Thézé, J., Bonsall, M.B., Bowden, T.A., Rissanen, I., et al. Zika virus in the Americas: Early epidemiological and genetic findings. Science 352 (2016), 345–349.
11. Ferlenghi, I., Clarke, M., Ruttan, T., Allison, S.L., Schalich, J., Heinz, F.X., Harrison, S.C., Rey, F.A., Fuller, S.D., Molecular organization of a recombinant subviral particle from tick-borne encephalitis virus. Mol. Cell 7 (2001), 593–602.
12. Govero, J., Esakky, P., Scheaffer, S.M., Fernandez, E., Drury, A., Platt, D.J., Gorman, M.J., Richner, J.M., Caine, E.A., Salazar, V., et al. Zika virus infection damages the testes in mice. Nature 540 (2016), 438–442.
13. Guy, B., Jackson, N., Dengue vaccine: hypotheses to understand CYD-TDV-induced protection. Nat. Rev. Microbiol. 14 (2016), 45–54.
14. Heinz, F.X., Stiasny, K., The Antigenic Structure of Zika Virus and Its Relation to Other Flaviviruses: Implications for Infection and Immunoprophylaxis. Microbiol. Mol. Biol. Rev., 81, 2017 e00055–e16.
15. Khan, S., Woodruff, E.M., Trapecar, M., Fontaine, K.A., Ezaki, A., Borbet, T.C., Ott, M., Sanjabi, S., Dampened antiviral immunity to intravaginal exposure to RNA viral pathogens allows enhanced viral replication. J. Exp. Med. 213 (2016), 2913–2929.
16. Kim, J., Mohanty, S., Ganesan, L.P., Hua, K., Jarjoura, D., Hayton, W.L., Robinson, J.M., Anderson, C.L., FcRn in the yolk sac endoderm of mouse is required for IgG transport to fetus. J. Immunol. 182 (2009), 2583–2589.
17. Kuhn, R.J., Zhang, W., Rossmann, M.G., Pletnev, S.V., Corver, J., Lenches, E., Jones, C.T., Mukhopadhyay, S., Chipman, P.R., Strauss, E.G., et al. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108 (2002), 717–725.
18. Lanciotti, R.S., Kosoy, O.L., Laven, J.J., Velez, J.O., Lambert, A.J., Johnson, A.J., Stanfield, S.M., Duffy, M.R., Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg. Infect. Dis. 14 (2008), 1232–1239.
19. Larocca, R.A., Abbink, P., Peron, J.P., Zanotto, P.M., Iampietro, M.J., Badamchi-Zadeh, A., Boyd, M., Ng'ang'a, D., Kirilova, M., Nityanandam, R., et al. Vaccine protection against Zika virus from Brazil. Nature 536 (2016), 474–478.
20. Lazear, H.M., Diamond, M.S., Zika Virus: New Clinical Syndromes and Its Emergence in the Western Hemisphere. J. Virol. 90 (2016), 4864–4875.
21. Lazear, H.M., Govero, J., Smith, A.M., Platt, D.J., Fernandez, E., Miner, J.J., Diamond, M.S., A Mouse Model of Zika Virus Pathogenesis. Cell Host Microbe 19 (2016), 720–730.
22. Ma, W., Li, S., Ma, S., Jia, L., Zhang, F., Zhang, Y., Zhang, J., Wong, G., Zhang, S., Lu, X., et al. Zika Virus Causes Testis Damage and Leads to Male Infertility in Mice. Cell 167 (2016), 1511–1524.e10.
23. Mansuy, J.M., Suberbielle, E., Chapuy-Regaud, S., Mengelle, C., Bujan, L., Marchou, B., Delobel, P., Gonzalez-Dunia, D., Malnou, C.E., Izopet, J., Martin-Blondel, G., Zika virus in semen and spermatozoa. Lancet Infect. Dis. 16 (2016), 1106–1107.
24. Miner, J.J., Cao, B., Govero, J., Smith, A.M., Fernandez, E., Cabrera, O.H., Garber, C., Noll, M., Klein, R.S., Noguchi, K.K., et al. Zika Virus Infection during Pregnancy in Mice Causes Placental Damage and Fetal Demise. Cell 165 (2016), 1081–1091.
25. Muller, D.A., Young, P.R., The flavivirus NS1 protein: molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarker. Antiviral Res. 98 (2013), 192–208.
26. Murray, K.O., Gorchakov, R., Carlson, A.R., Berry, R., Lai, L., Natrajan, M., Garcia, M.N., Correa, A., Patel, S.M., Aagaard, K., Mulligan, M.J., Prolonged Detection of Zika Virus in Vaginal Secretions and Whole Blood. Emerg. Infect. Dis. 23 (2017), 99–101.
27. Muthumani, K., Griffin, B.D., Agarwal, S., Kudchodkar, S.B., Reuschel, E.L., Choi, H., Kraynyak, K.A., Duperret, E.K., Keaton, A.A., Chung, C., et al. In vivo protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv DNA vaccine. NPJ Vaccines, 2016, 10.1038/npjvaccines.2016.1021 Published online November 10, 2016.
28. Muylaert, I.R., Chambers, T.J., Galler, R., Rice, C.M., Mutagenesis of the N-linked glycosylation sites of the yellow fever virus NS1 protein: effects on virus replication and mouse neurovirulence. Virology 222 (1996), 159–168.
29. Oehler, E., Watrin, L., Larre, P., Leparc-Goffart, I., Lastere, S., Valour, F., Baudouin, L., Mallet, H., Musso, D., Ghawche, F., Zika virus infection complicated by Guillain-Barre syndrome–case report, French Polynesia, December 2013. Euro Surveill., 19, 2014, 20720.
30. Pardi, N., Weissman, D., Nucleoside Modified mRNA Vaccines for Infectious Diseases. Methods Mol. Biol. 1499 (2017), 109–121.
31. Pardi, N., Hogan, M.J., Pelc, R.S., Muramatsu, H., Andersen, H., DeMaso, C.R., Dowd, K.A., Sutherland, L.L., Scearce, R.M., Parks, R., et al. Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination. Nature 543 (2017), 248–251.
32. Pentsuk, N., van der Laan, J.W., An interspecies comparison of placental antibody transfer: new insights into developmental toxicity testing of monoclonal antibodies. Birth Defects Res. B Dev. Reprod. Toxicol. 86 (2009), 328–344.
33. Pierson, T.C., Diamond, M.S., Flaviviruses. Knipe, D.M., Howley, P.M., (eds.) Fields Virology, 2013, Lippincott Williams & Wilkins, 747–794.
34. Prasad, V.M., Miller, A.S., Klose, T., Sirohi, D., Buda, G., Jiang, W., Kuhn, R.J., Rossmann, M.G., Structure of the immature Zika virus at 9 Å resolution. Nat. Struct. Mol. Biol. 24 (2017), 184–186.
35. Pryor, M.J., Gualano, R.C., Lin, B., Davidson, A.D., Wright, P.J., Growth restriction of dengue virus type 2 by site-specific mutagenesis of virus-encoded glycoproteins. J. Gen. Virol. 79 (1998), 2631–2639.
36. Rasmussen, S.A., Jamieson, D.J., Honein, M.A., Petersen, L.R., Zika Virus and Birth Defects–Reviewing the Evidence for Causality. N. Engl. J. Med. 374 (2016), 1981–1987.
37. Richner, J.M., Himansu, S., Dowd, K.A., Butler, S.L., Salazar, V., Fox, J.M., Julander, J.G., Tang, W.W., Shresta, S., Pierson, T.C., et al. Modified mRNA Vaccines Protect against Zika Virus Infection. Cell 168 (2017), 1114–1125.e10.
38. Rossi, S.L., Tesh, R.B., Azar, S.R., Muruato, A.E., Hanley, K.A., Auguste, A.J., Langsjoen, R.M., Paessler, S., Vasilakis, N., Weaver, S.C., Characterization of a Novel Murine Model to Study Zika Virus. Am. J. Trop. Med. Hyg. 94 (2016), 1362–1369.
39. Sapparapu, G., Fernandez, E., Kose, N., Bin Cao, Fox, J.M., Bombardi, R.G., Zhao, H., Nelson, C.A., Bryan, A.L., Barnes, T., et al. Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice. Nature 540 (2016), 443–447.
40. Schlake, T., Thess, A., Fotin-Mleczek, M., Kallen, K.J., Developing mRNA-vaccine technologies. RNA Biol. 9 (2012), 1319–1330.
41. Shan, C., Xie, X., Muruato, A.E., Rossi, S.L., Roundy, C.M., Azar, S.R., Yang, Y., Tesh, R.B., Bourne, N., Barrett, A.D., et al. An Infectious cDNA Clone of Zika Virus to Study Viral Virulence, Mosquito Transmission, and Antiviral Inhibitors. Cell Host Microbe 19 (2016), 891–900.
42. Shan, C., Muruato, A.E., Nunes, B.T.D., Luo, H., Xie, X., Medeiros, D.B.A., Wakamiya, M., Tesh, R.B., Barrett, A.D., Wang, T., et al. A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models. Nat. Med. 23 (2017), 763–767.
43. Shan, C., Xie, X., Ren, P., Loeffelholz, M.J., Yang, Y., Furuya, A., Dupuis, A.P. 2nd, Kramer, L.D., Wong, S.J., Shi, P.Y., A Rapid Zika Diagnostic Assay to Measure Neutralizing Antibodies in Patients. EBioMedicine 17 (2017), 157–162.
44. Sheehan, K.C., Lai, K.S., Dunn, G.P., Bruce, A.T., Diamond, M.S., Heutel, J.D., Dungo-Arthur, C., Carrero, J.A., White, J.M., Hertzog, P.J., Schreiber, R.D., Blocking monoclonal antibodies specific for mouse IFN-alpha/beta receptor subunit 1 (IFNAR-1) from mice immunized by in vivo hydrodynamic transfection. J. Interferon Cytokine Res. 26 (2006), 804–819.
45. Shi, P.Y., Tilgner, M., Lo, M.K., Kent, K.A., Bernard, K.A., Infectious cDNA clone of the epidemic west nile virus from New York City. J. Virol. 76 (2002), 5847–5856.
46. Shin, H., Iwasaki, A., Generating protective immunity against genital herpes. Trends Immunol. 34 (2013), 487–494.
47. Somnuke, P., Hauhart, R.E., Atkinson, J.P., Diamond, M.S., Avirutnan, P., N-linked glycosylation of dengue virus NS1 protein modulates secretion, cell-surface expression, hexamer stability, and interactions with human complement. Virology 413 (2011), 253–264.
48. Uraki, R., Hwang, J., Jurado, K.A., Householder, S., Yockey, L.J., Hastings, A.K., Homer, R.J., Iwasaki, A., Fikrig, E., Zika virus causes testicular atrophy. Sci. Adv., 3, 2017, e1602899.
49. Whiteman, M.C., Li, L., Wicker, J.A., Kinney, R.M., Huang, C., Beasley, D.W., Chung, K.M., Diamond, M.S., Solomon, T., Barrett, A.D., Development and characterization of non-glycosylated E and NS1 mutant viruses as a potential candidate vaccine for West Nile virus. Vaccine 28 (2010), 1075–1083.
50. Whiteman, M.C., Wicker, J.A., Kinney, R.M., Huang, C.Y., Solomon, T., Barrett, A.D., Multiple amino acid changes at the first glycosylation motif in NS1 protein of West Nile virus are necessary for complete attenuation for mouse neuroinvasiveness. Vaccine 29 (2011), 9702–9710.
51. Yang, Y., Shan, C., Zou, J., Muruato, A.E., Bruno, D.N., de Almeida Medeiros Daniele, B., Vasconcelos, P.F., Rossi, S.L., Weaver, S.C., Xie, X., Shi, P.Y., A cDNA Clone-Launched Platform for High-Yield Production of Inactivated Zika Vaccine. EBioMedicine 17 (2017), 145–156.
52. Yockey, L.J., Varela, L., Rakib, T., Khoury-Hanold, W., Fink, S.L., Stutz, B., Szigeti-Buck, K., Van den Pol, A., Lindenbach, B.D., Horvath, T.L., Iwasaki, A., Vaginal Exposure to Zika Virus during Pregnancy Leads to Fetal Brain Infection. Cell 166 (2016), 1247–1256.e4.
53. Zhao, H., Fernandez, E., Dowd, K.A., Speer, S.D., Platt, D.J., Gorman, M.J., Govero, J., Nelson, C.A., Pierson, T.C., Diamond, M.S., Fremont, D.H., Structural Basis of Zika Virus-Specific Antibody Protection. Cell 166 (2016), 1016–1027.